The World Health Organisation (WHO) is investigating a potential link between a cough syrup made and manufactured in India and the death of more than 60 children in Gambia. Two WHO officials from India reportedly said the medicine could cause kidney damage, reports Reuters.
It's understood 66 youngsters from Gambia tragically died after using the medicine, but little has been shared about symptoms they experienced. Ministers and health organisations in India are now waiting on an official report to confirm or deny whether there was a "causal relation to death with the medical products in question".
Director-general at WHO, Tedros Adhanom has confirmed to Reuters that the organisation is investigating deaths from "acute kidney injuries" with India's drug regulator and New Delhi-based cough syrup manufacturer Maiden Pharmaceuticals. You can get more consumer news and other story updates straight to your inbox by subscribing to our newsletters here.
